发明申请
US20110123525A1 ANTI-ANGIOGENIC THERAPY 有权
抗生素治疗

ANTI-ANGIOGENIC THERAPY
摘要:
The present invention provides novel monoclonal antibodies directed to PlGF and fragments and derivatives thereof, more particularly to humanized antibodies and fragments thereof for use in the treatment and/or prevention of pathological angiogenesis.
公开/授权文献
信息查询
0/0